Dáil Éireann Debate, Tuesday - 6 October 2015
539. Deputy Charlie McConalogue asked the Minister for Health the situation regarding the Health Service Executive's position on the drug Fampyra (details supplied); and if he will make a statement on the matter. [34474/15]
View answerThe Health Service Executive has confirmed that Fampridine (brand name Fampyra®) is being reimbursed under the Long Term Illness Scheme from 1st October 2015.
Reimbursement will be extended where a demonstration of clinical response (based on objective criteria agreed with clinical experts) is recorded and where that clinical response is shown to persist, based on objective measurement at six-month intervals.
